Year archive

HBM Holdings Limited — 2022 filings

All 58 regulatory filings released by HBM Holdings Limited (2142) in 2022, sourced directly from the official regulator.

58 Filings

2022 Period

2022 filings (58)

Filing	Released	Lang
INSIDE INFORMATION - FURTHER BUSINESS UPDATE ON COLLABORATION WITH KELUN-BIOTECH IN CONNECTION WITH ANTIBODY-DRUG CONJUGATE Capital/Financing Update	2022-12-23	English
SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION DISPOSAL OF ASSETS Capital/Financing Update	2022-12-22	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE OF COLLABORATION WITH KELUN-BIOTECH Regulatory Filings	2022-12-08	English
VOLUNTARY ANNOUNCEMENT - RESULTS FROM PHASE I CLINICAL TRIAL OF PORUSTOBART (HBM4003) IN COMBINATION WITH TORIPALIMAB IN ADVANCED MELANOMA Regulatory Filings	2022-12-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 Regulatory Filings	2022-12-06	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO COLLABORATION AGREEMENT WITH DRAGONFLY THERAPEUTICS Capital/Financing Update	2022-11-21	English
DISCLOSEABLE TRANSACTION - DISPOSAL OF ASSETS Capital/Financing Update	2022-11-15	English
CHANGE IN CHIEF FINANCIAL OFFICER AND APPOINTMENT OF CHIEF BUSINESS OFFICER Board/Management Information	2022-11-11	English
INSIDE INFORMATION - ENTERING INTO LICENSE AND COLLABORATION AGREEMENT WITH MODERNATX, INC. Regulatory Filings	2022-11-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 Share Issue/Capital Change	2022-11-03	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST DOSING OF FIRST PATIENT OF B7H4X4-1BB BISPECIFIC ANTIBODY (HBM7008) PHASE I TRIALS IN THE UNITED STATES Regulatory Filings	2022-10-20	English
INSIDE INFORMATION - CLOSING THE STUDY OF PHASE III CLINICAL TRIAL OF TANFANERCEPT (HBM9036) Regulatory Filings	2022-10-10	English
INSIDE INFORMATION - LICENSE AGREEMENT WITH CSPC NBP PHARMACEUTICAL CO. LTD. FOR BATOCLIMAB (HBM9161) AND CHANGE IN USE OF PROCEEDS Capital/Financing Update	2022-10-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 Regulatory Filings	2022-10-07	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST DOSING OF LAST PATIENT WITH HBM4003 PHASE Ib/II TRIAL Regulatory Filings	2022-10-03	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST DOSING OF FIRST PATIENT OF ANTI-TSLP FULLY HUMAN MONOCLONAL ANTIBODY (HBM9378) IN ASTHMA PHASE I TRIAL IN CHINA Regulatory Filings	2022-09-27	English
Interim Report 2022 Interim / Quarterly Report	2022-09-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022 Share Issue/Capital Change	2022-09-06	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022 Interim / Quarterly Report	2022-08-31	English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG AND CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE Regulatory Filings	2022-08-15	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST DOSING OF LAST PATIENT WITH HBM4003 PHASE Ib TRIAL Regulatory Filings	2022-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022 Regulatory Filings	2022-08-04	English
DATE OF BOARD MEETING Regulatory Filings	2022-08-02	English
GRANT OF SHARE OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION SCHEME AND GRANT OF SHARE AWARDS PURSUANT TO THE POST-IPO SHARE AWARD SCHEME Transaction in Own Shares	2022-07-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022 Regulatory Filings	2022-07-07	English
VOLUNTARY ANNOUNCEMENT - FOOD AND DRUG ADMINISTRATION OF THE UNITED STATES IND CLEARANCE FOR B7H4X4-1BB BISPECIFIC ANTIBODY Regulatory Filings	2022-06-27	English
SEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2022-06-08	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 8 JUNE 2022 Declaration of Voting Results & Voting Rights Announcements	2022-06-08	English
VOLUNTARY ANNOUNCEMENT - IND APPROVAL FOR COMMENCEMENT OF PHASE I TRIAL OF B7H4X4-1BB BISPECIFIC ANTIBODY IN CHINA Regulatory Filings	2022-06-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 Share Issue/Capital Change	2022-06-07	English
VOLUNTARY ANNOUNCEMENT - DATA RELEASE OF NEXT-GEN CTLA-4 ANTIBODY AT ASCO 2022 Capital/Financing Update	2022-06-01	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE OF COLLABORATION ON ANTIBODY-DRUG CONJUGATE Regulatory Filings	2022-05-30	English
CHANGE OF ANNUAL GENERAL MEETING TO BE HELD ON 8 JUNE 2022 TO VIRTUAL MEETING AGM Information	2022-05-25	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST DOSING OF FIRST PATIENT OF B7H4X4-1BB BISPECIFIC ANTIBODY (HBM7008) PHASE I TRIALS Capital/Financing Update	2022-05-25	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING AGM Information	2022-05-11	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2022-05-11	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING AGM Information	2022-05-11	English
PROPOSED ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY Governance Information	2022-05-11	English
VOLUNTARY ANNOUNCEMENT - DATA RELEASE FORECAST OF HBM4003 AT ASCO 2022 Regulatory Filings	2022-05-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022 Regulatory Filings	2022-05-06	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-05-05	English
CHANGE OF EXECUTIVE DIRECTOR Board/Management Information	2022-05-05	English
Environmental, Social and Governance Report 2021 Environmental & Social Information	2022-04-28	English
Annual Report 2021 Annual Report	2022-04-28	English
APPOINTMENT OF CHIEF MEDICAL OFFICER Board/Management Information	2022-04-14	English
INSIDE INFORMATION - ENTERING INTO THE OUT-LICENSE AGREEMENT WITH ASTRAZENECA FOR HBM7022 Regulatory Filings	2022-04-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022 Share Issue/Capital Change	2022-04-06	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021 Annual Report	2022-03-24	English
DATE OF BOARD MEETING Regulatory Filings	2022-03-14	English
RENEWAL OF CONTINUING CONNECTED TRANSACTIONS Regulatory Filings	2022-03-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022 Share Issue/Capital Change	2022-03-04	English
VOLUNTARY ANNOUNCEMENT - IRB APPROVAL FOR COMMENCEMENT OF PHASE I TRIAL OF B7H4X4-1BB BISPECIFIC ANTIBODY IN AUSTRALIA Regulatory Filings	2022-02-28	English
VOLUNTARY ANNOUNCEMENT - IND Approval for Anti-TSLP Fully Human Monoclonal Antibody in Asthma Regulatory Filings	2022-02-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022 Regulatory Filings	2022-02-09	English
VOLUNTARY ANNOUNCEMENT - DOSING OF FIRST PATIENT IN PHIB/IIA TRIAL OF NEXT-GENERATION ANTI-CTLA-4 ANTIBODY IN CHINA Regulatory Filings	2022-01-24	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST INTERIM ANALYSIS OF PHASE III CLINICAL TRIAL OF TANFANERCEPT (HBM9036) Regulatory Filings	2022-01-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021 Share Issue/Capital Change	2022-01-06	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST DOSING OF FIRST PATIENT WITH TWO HBM4003 PHASE I TRIALS Regulatory Filings	2022-01-03	English